Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

PURPOSE: The EML4-ALK fusion oncogene represents a novel molecular target in a small subset of non–small-cell lung cancers (NSCLC). To aid in identification and treatment of these patients, we examined the clinical characteristics and treatment outcomes of patients who had NSCLC with and without EML...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shaw, Alice T., Yeap, Beow Y., Mino-Kenudson, Mari, Digumarthy, Subba R., Costa, Daniel B., Heist, Rebecca S., Solomon, Benjamin, Stubbs, Hannah, Admane, Sonal, McDermott, Ultan, Settleman, Jeffrey, Kobayashi, Susumu, Mark, Eugene J., Rodig, Scott J., Chirieac, Lucian R., Kwak, Eunice L., Lynch, Thomas J., Iafrate, A. John
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2009
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744268/
https://ncbi.nlm.nih.gov/pubmed/19667264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.6993
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky